Haisco Pharmaceutical Group Co., Ltd.

This study tests a new tablet called HSK44459 for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. About 420 adults aged 40 and older will receive either the drug or a placebo for 52 weeks. The main goal is to see if t…

This study tests a new medicine called cofrogliptin against an older one, acarbose, in 200 adults with type 2 diabetes who have never taken diabetes drugs. The goal is to see which works better at lowering blood sugar and has fewer side effects. Participants will take one of the …

This study looks at the long-term safety of an experimental inhaled drug called HSK39004 for people with moderate-to-severe COPD. About 300 adults aged 40 to 80 will take the drug twice daily for 52 weeks. The goal is to monitor side effects and see if the drug remains safe over …

This study tests a new tablet called HSK44459 for adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. The main goal is to see if the drug improves lung function after one year. About 378 participants will receive either the drug or a pla…

This study tests an experimental oral medication called HSK44459 for adults with moderate to severe plaque psoriasis. About 150 participants will receive either the drug or a placebo to see if it can reduce skin symptoms by at least 75% after 16 weeks. The goal is to control the …

This study tests a new drug called HSK47388 in 220 adults with moderate-to-severe plaque psoriasis. Participants will receive either the drug or a placebo to see if it improves skin symptoms like redness, thickness, and scaling. The main goal is to measure how many people achieve…

This study compares a new anesthetic called cipepofol to the standard drug propofol for putting children (ages 3-17) to sleep before elective surgery. The goal is to see if cipepofol works just as well and causes less pain at the injection site. About 400 children will take part …

This study tests a new medicine called HSK55718 to see if it can safely reduce pain after orthopedic surgery. About 200 adults will receive either the new drug, morphine, or a placebo. The goal is to find better ways to manage pain after surgery.

This study tests an experimental drug called HSK55718 to see if it can safely reduce pain after abdominal surgery. About 200 adults will be randomly assigned to receive HSK55718, morphine, or a placebo. The main goal is to measure how much pain relief the drug provides over time.

This early-stage study tests a new drug called HSK56630 for the first time in humans. It involves 40 healthy adults to check the drug's safety, side effects, and how the body processes it. No treatment or health benefit is expected for participants.